These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 6941665)

  • 1. HDL-cholesterol, triglycerides and vascular complications in essential hypertension.
    Kristensen BO
    Acta Med Scand Suppl; 1981; 646():31-42. PubMed ID: 6941665
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of different antihypertensive therapies on plasma lipids.
    Gomez G
    Practitioner; 1982 May; 226(1367):985-91. PubMed ID: 7100090
    [No Abstract]   [Full Text] [Related]  

  • 3. Metabolic effects of propranolol and hydroflumethiazide treatment in Kenyans with mild to moderate essential hypertension.
    Yonga GO; Ogola EN; Orinda DA
    East Afr Med J; 1993 Nov; 70(11):696-700. PubMed ID: 8033771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-density and low-density lipoproteins and prevalence of vascular disease in diabetes mellitus.
    Reckless JP; Betteridge DJ; Wu P; Payne B; Galton DJ
    Br Med J; 1978 Apr; 1(6117):883-6. PubMed ID: 205308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of propranolol treatment on total cholesterol, HDL cholesterol, triglycerides. Postheparin lipolytic activity and lecithin:cholesterol acyltransferase in hypertensive individuals.
    Schauer I; Schauer U; Rühling K; Thielmann K
    Artery; 1980; 8(2):146-50. PubMed ID: 7458680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of blood pressure, plasma lipid and cardiac performance responses to prazosin versus propranolol in thiazide-treated hypertensive patients.
    Misson R; Merkel T; Cutler RE
    Am J Cardiol; 1984 Jan; 53(3):51A-54A. PubMed ID: 6364760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adrenergic mechanisms in control of plasma lipid concentrations.
    Day JL; Metcalfe J; Simpson CN
    Br Med J (Clin Res Ed); 1982 Apr; 284(6323):1145-8. PubMed ID: 6122483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of atenolol on plasma HDL cholesterol subfractions.
    Lehtonen A; Marniemi J
    Atherosclerosis; 1984; 51(2-3):335-8. PubMed ID: 6743386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intraindividual variability of plasma cholesterol and triglycerides and the effect of propranolol treatment.
    Rühling K; Schauer I; Thielmann K
    Artery; 1980; 8(2):140-5. PubMed ID: 7458679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipid effects of celiprolol, a new cardioselective beta-blocker, versus propranolol.
    Sirtori CR; Johnson B; Vaccarino V; Montanari G; Cremoncini M; Gianfranceschi G; Sirtori M; Dujovne CA
    Clin Pharmacol Ther; 1989 Jun; 45(6):617-26. PubMed ID: 2567218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Distribution and magnitude of triglyceridemia and risk index (total cholesterol/HDL cholesterol ratio) in a population of 94 hospitalized subjects].
    Lovreglio V; Sannito N; Leuce U; Miglionico A; Simini P; De Cesare L
    Boll Soc Ital Cardiol; 1981; 26(7):663-72. PubMed ID: 7347264
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of trimazosin on serum lipid profiles in hypertensive patients.
    Singleton W; Taylor CR
    Am Heart J; 1983 Nov; 106(5 Pt 2):1265-8. PubMed ID: 6356856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of hydrochlorothiazide on the plasma levels of triglycerides, total cholesterol and HDL-cholesterol in patients with essential hypertension.
    van Brummelen P; Gevers Leuven JA; van Gent CM
    Curr Med Res Opin; 1979; 6(1):24-9. PubMed ID: 222539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative effects of propranolol and prazosin upon serum lipids in thiazide- treated hypertensive patients.
    Johnson BF; Romero L; Johnson J; Marwaha R
    Am J Med; 1984 Feb; 76(2A):109-12. PubMed ID: 6367445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HDL-cholesterol in antihypertensive treatment. The Oslo Study.
    Helgeland A; Leren P; Enger SC; Hjermann I; Holme I
    Acta Med Scand Suppl; 1979; 625():131-4. PubMed ID: 219665
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of long-term treatment with beta-blocking drugs on plasma lipids and lipoproteins.
    Kristensen BO
    Br Med J (Clin Res Ed); 1981 Jul; 283(6285):191-2. PubMed ID: 6114770
    [No Abstract]   [Full Text] [Related]  

  • 17. [Diabetes mellitus, HDL-cholesterol and vascular disease].
    Rubiés-Prat J; Masdeu S; Masana L; Nubiola AR
    Med Clin (Barc); 1982 Nov 1-15; 79(8):348-50. PubMed ID: 7176746
    [No Abstract]   [Full Text] [Related]  

  • 18. [Cholesterol, free cholesterol, HDL, LDL, triglycerides, LCAT. Evaluation of some risk factors for cardiovascular diseases].
    Andreoli D; Lattuada L; Giovanelli E; Persico D
    Quad Sclavo Diagn; 1982 Jun; 18(2):127-31. PubMed ID: 7167633
    [No Abstract]   [Full Text] [Related]  

  • 19. The effect on HDL cholesterol of oxprenolol and atenolol.
    Kjeldsen SE; Eide I; Leren P; Foss OP; Holme I; Eriksen IL
    Scand J Clin Lab Invest; 1982 Sep; 42(5):449-53. PubMed ID: 6130595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum high-density lipoproteins cholesterol, heparin and peripheral vascular disease.
    Masana L; Rubiés-Prat J; Nubiola AR; Masdeu S; de Sobregrau RC
    Biomedicine; 1981 May; 35(2):42-3. PubMed ID: 7260236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.